Chronic kidney disease: effects on the cardiovascular system - PubMed (original) (raw)
Review
Chronic kidney disease: effects on the cardiovascular system
Ernesto L Schiffrin et al. Circulation. 2007.
Abstract
Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the progression of renal failure. Furthermore, diabetic nephropathy is the leading cause of renal failure in developed countries. Together, hypertension, dyslipidemia, and diabetes are major risk factors for the development of endothelial dysfunction and progression of atherosclerosis. Inflammatory mediators are often elevated and the renin-angiotensin system is frequently activated in chronic kidney disease, which likely contributes through enhanced production of reactive oxygen species to the accelerated atherosclerosis observed in chronic kidney disease. Promoters of calcification are increased and inhibitors of calcification are reduced, which favors metastatic vascular calcification, an important participant in vascular injury associated with end-stage renal disease. Accelerated atherosclerosis will then lead to increased prevalence of coronary artery disease, heart failure, stroke, and peripheral arterial disease. Consequently, subjects with chronic renal failure are exposed to increased morbidity and mortality as a result of cardiovascular events. Prevention and treatment of cardiovascular disease are major considerations in the management of individuals with chronic kidney disease.
Similar articles
- [Vascular damage in chronic kidney disease].
Jara A, Mezzano S. Jara A, et al. Rev Med Chil. 2008 Nov;136(11):1476-84. doi: 10.4067/s0034-98872008001100016. Rev Med Chil. 2008. PMID: 19301781 Review. Spanish. - [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
Ratto E, Leoncini G, Viazzi F, Pontremoli R. Ratto E, et al. G Ital Nefrol. 2008 Jan-Feb;25(1):21-31. G Ital Nefrol. 2008. PMID: 18264915 Review. Italian. - Slowing progression along the renal disease continuum.
Kopyt NP. Kopyt NP. J Am Osteopath Assoc. 2005 Apr;105(4):207-15. J Am Osteopath Assoc. 2005. PMID: 15928338 Review. - Time to abandon microalbuminuria?
Ruggenenti P, Remuzzi G. Ruggenenti P, et al. Kidney Int. 2006 Oct;70(7):1214-22. doi: 10.1038/sj.ki.5001729. Epub 2006 Jul 26. Kidney Int. 2006. PMID: 16871239 Review. - Metabolic pathogenesis of cardiorenal disease.
Keane WF. Keane WF. Am J Kidney Dis. 2001 Dec;38(6):1372-5. doi: 10.1053/ajkd.2001.29260. Am J Kidney Dis. 2001. PMID: 11728977 Review.
Cited by
- An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.
Tumelty E, Chung I, Hussain S, Ali MA, Addada H, Banerjee D. Tumelty E, et al. Rev Cardiovasc Med. 2024 Apr 11;25(4):144. doi: 10.31083/j.rcm2504144. eCollection 2024 Apr. Rev Cardiovasc Med. 2024. PMID: 39076544 Free PMC article. Review. - Ventricular arrhythmias in the context of chronic kidney disease and electrolyte imbalance.
Masmoudi I, Dindane Z, Richter S, Ebert M. Masmoudi I, et al. Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):211-218. doi: 10.1007/s00399-024-01029-7. Epub 2024 Jul 15. Herzschrittmacherther Elektrophysiol. 2024. PMID: 39008102 Review. English. - Molecular Interaction of Soluble Klotho with FGF23 in the Pathobiology of Aortic Valve Lesions Induced by Chronic Kidney Disease.
The E, Zhai Y, Yao Q, Ao L, Fullerton DA, Meng X. The E, et al. Int J Biol Sci. 2024 Jun 17;20(9):3412-3425. doi: 10.7150/ijbs.92447. eCollection 2024. Int J Biol Sci. 2024. PMID: 38993571 Free PMC article. - Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.
Chou CL, Chiu HW, Hsu YH, Yu SM, Liou TH, Sung LC. Chou CL, et al. Sci Rep. 2024 Jul 9;14(1):15770. doi: 10.1038/s41598-024-66655-0. Sci Rep. 2024. PMID: 38982230 Free PMC article. - Management of chronic kidney disease: The current novel and forgotten therapies.
Pethő ÁG, Tapolyai M, Csongrádi É, Orosz P. Pethő ÁG, et al. J Clin Transl Endocrinol. 2024 May 22;36:100354. doi: 10.1016/j.jcte.2024.100354. eCollection 2024 Jun. J Clin Transl Endocrinol. 2024. PMID: 38828402 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous